Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Cost of Revenue (2025)

Medicinova (MNOV) has disclosed Cost of Revenue for 2 consecutive years, with $146985.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue changed N/A to $146985.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a N/A change, with the full-year FY2025 number at $378606.0, changed N/A from a year prior.
  • Cost of Revenue was $146985.0 for Q4 2025 at Medicinova, up from $116349.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $146985.0 in Q4 2025 to a low of $116349.0 in Q2 2025.